FDA approves pancreatic cancer drug that extends patients’ lives



In trials, Revolution Medicines’ daraxonrasib nearly doubled average survival times for one of the deadliest cancers.



Source link

  • Related Posts

    Bryan Kohberger granted new hearing in bid to take back guilty plea in Idaho murders: Court filings

    Bryan Kohberger, who pleaded guilty last year to the University of Idaho quadruple murders, has been granted a new hearing in his bid to take back his guilty plea, according to court…

    FDA approves new pancreatic cancer drug that could extend patients’ lives

    The Food and Drug Administration on Wednesday approved a groundbreaking new drug for advanced pancreatic cancer, offering U.S. patients a more effective treatment against one of the deadliest types of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    No. 1 recruit Brewster reaffirms commitment to Texas Tech

    No. 1 recruit Brewster reaffirms commitment to Texas Tech

    How to See the Partial Lunar Eclipse and Blood Moon on August 27

    How to See the Partial Lunar Eclipse and Blood Moon on August 27

    Tim Curry, star of ‘Rocky Horror Picture Show,’ dies at 80

    Tim Curry, star of ‘Rocky Horror Picture Show,’ dies at 80

    Canada adds 75,000 new jobs in July, unemployment…

    Humanoid Global Announces CEO Transition

    The Shoe Trends to Wear With Shorts from Summer-to-Fall 2026

    The Shoe Trends to Wear With Shorts from Summer-to-Fall 2026